Arkolith/Insider Trading/VIRI

VIRI Insider Trading

Virios Therapeutics, Inc. · full profile →Last filing Jun 16, 2026

Virios Therapeutics, Inc. also files under DWTX; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 16, 2026Keefer David RDirectorGrant(A)17K—$0
Jun 16, 2026Whitley Richard JamesDirectorGrant(A)17K—$0
Jun 16, 2026Thomas John CDirectorGrant(A)17K—$0
Jun 16, 2026De La Rosa AbelDirectorGrant(A)17K—$0
Mar 5, 2026Walsh AngelaChief Financial OfficerGrant(A)83K—$0
Mar 5, 2026Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)83K—$0
Mar 5, 2026Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)330K—$0
Mar 5, 2026Grosswald RalphSVP OF OPERATIONSGrant(A)83K—$0
Dec 4, 2025Walsh AngelaChief Financial OfficerGrant(A)150K—$0
Dec 4, 2025Grosswald RalphSVP OF OPERATIONSGrant(A)150K—$0
Dec 4, 2025Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)150K—$0
Dec 4, 2025Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)460K—$0
Nov 21, 2025Conjoint Inc.Director, 10% OwnerConversion(C)2.8M——
Nov 21, 2025Conjoint Inc.Director, 10% OwnerConversion(C)284—$0
Nov 21, 2025Conjoint Inc.Director, 10% OwnerConversion(C)2K—$0
Nov 21, 2025Conjoint Inc.Director, 10% OwnerConversion(C)21.6M——
Jun 27, 2025Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)12K—$0
Jun 27, 2025De La Rosa AbelDirectorGrant(A)2K—$0
Jun 27, 2025Walsh AngelaChief Financial OfficerGrant(A)12K—$0
Jun 27, 2025Keefer David RDirectorGrant(A)2K—$0
Jun 27, 2025Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)40K—$0
Jun 27, 2025Thomas John CDirectorGrant(A)2K—$0
Jun 27, 2025Grosswald RalphSVP OF OPERATIONSGrant(A)12K—$0
Jun 27, 2025Whitley Richard JamesDirectorGrant(A)2K—$0
Jun 18, 2025Keefer David RDirectorGrant(A)210—$0
Jun 18, 2025Whitley Richard JamesDirectorGrant(A)210—$0
Jun 18, 2025Whitley Richard JamesDirectorGrant(A)210—$0
Jun 18, 2025Keefer David RDirectorGrant(A)210—$0
Jun 18, 2025Thomas John CDirectorGrant(A)210—$0
Jun 18, 2025Thomas John CDirectorGrant(A)210—$0
Jun 18, 2025De La Rosa AbelDirectorGrant(A)210—$0
Jun 18, 2025De La Rosa AbelDirectorGrant(A)210—$0
Mar 12, 2025CK Life Sciences Intl (Holdings) IncDirector, 10% OwnerGrant(A)284$7.01$2K
Feb 26, 2024Pridgen WilliamDirectorGrant(A)3K—$0
Feb 26, 2024De La Rosa AbelDirectorGrant(A)4K—$0
Feb 26, 2024Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)139K—$0
Feb 26, 2024Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)88K—$0
Feb 26, 2024Grosswald RalphSVP OF OPERATIONSGrant(A)63K—$0
Feb 26, 2024Walsh AngelaSVP OF FINANCEGrant(A)64K—$0
Feb 26, 2024Burch Richard AlanDirectorGrant(A)3K—$0
Feb 26, 2024Keefer David RDirectorGrant(A)5K—$0
Feb 26, 2024Whitley Richard JamesDirectorGrant(A)4K—$0
Feb 26, 2024Thomas John CDirectorGrant(A)4K—$0
Aug 21, 2023Pridgen WilliamDirectorBuy(P)15K$1.30$20K
Aug 17, 2023Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorBuy(P)25K$1.25$31K
Jun 15, 2023Whitley Richard JamesDirectorGrant(A)5K—$0
Jun 15, 2023Burch Richard AlanDirectorGrant(A)5K—$0
Jun 15, 2023Thomas John CDirectorGrant(A)5K—$0
Jun 15, 2023De La Rosa AbelDirectorGrant(A)5K—$0
Jun 15, 2023Keefer David RDirectorGrant(A)5K—$0
Jun 15, 2023Pridgen WilliamDirectorGrant(A)5K—$0
Dec 12, 2022Walsh AngelaSVP OF FINANCEGrant(A)80K—$0
Dec 12, 2022Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)410K—$0
Dec 12, 2022Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)80K—$0
Dec 12, 2022Grosswald RalphSVP OF OPERATIONSGrant(A)80K—$0
Dec 8, 2022Whitley Richard JamesDirectorSell(S)2K$0.26$468
Jun 23, 2022Burch Richard AlanDirectorGrant(A)5K—$0
Jun 23, 2022Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)90K—$0
Jun 23, 2022Walsh AngelaSVP OF FINANCEGrant(A)40K—$0
Jun 23, 2022Grosswald RalphSVP OF OPERATIONSGrant(A)40K—$0
Jun 23, 2022Gendreau Roger MichaelCHIEF MEDICAL OFFICERGrant(A)40K—$0
Jun 23, 2022De La Rosa AbelDirectorGrant(A)5K—$0
Jun 23, 2022Thomas John CDirectorGrant(A)5K—$0
Jun 23, 2022Keefer David RDirectorGrant(A)5K—$0
Jun 23, 2022Pridgen WilliamDirectorGrant(A)5K—$0
Jun 23, 2022Whitley Richard JamesDirectorGrant(A)5K—$0
May 23, 2022Walsh AngelaSVP OF FINANCEBuy(P)2K$4.58$9K
May 23, 2022Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorBuy(P)8K$4.52$34K
May 18, 2022Pridgen WilliamDirectorBuy(P)241$4.50$1K
May 18, 2022Whitley Richard JamesDirectorBuy(P)500$4.53$2K
May 17, 2022Pridgen WilliamDirectorBuy(P)13K$4.38$59K
Mar 29, 2022Pridgen WilliamDirectorBuy(P)600$4.94$3K
Mar 23, 2022Pridgen WilliamDirectorBuy(P)2K$5.46$12K
Jan 27, 2022Pridgen WilliamDirectorBuy(P)4K$5.98$25K
Jan 7, 2022De La Rosa AbelDirectorBuy(P)4K$5.90$24K
Jan 6, 2022Whitley Richard JamesDirectorBuy(P)2K$5.72$10K
Jan 4, 2022Keefer David RDirectorBuy(P)5K$5.80$29K
Jan 4, 2022Thomas John CDirectorBuy(P)1K$5.65$6K
Jan 3, 2022Pridgen WilliamDirectorBuy(P)2K$5.43$12K
Dec 23, 2021Whitley Richard JamesDirectorBuy(P)200$5.73$1K
Dec 21, 2021Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorBuy(P)5K$5.52$28K
Dec 21, 2021Pridgen WilliamDirectorBuy(P)9K$5.66$50K
Jul 7, 2021Pridgen WilliamDirectorBuy(P)942$6.32$6K
Jun 22, 2021Burch Richard AlanDirectorGrant(A)8K—$0
Jun 22, 2021Keefer David RDirectorGrant(A)8K—$0
Jun 22, 2021Thomas John CDirectorGrant(A)8K—$0
Jun 22, 2021Whitley Richard JamesDirectorGrant(A)8K—$0
Jun 22, 2021Pridgen WilliamDirectorGrant(A)8K—$0
Jun 22, 2021De La Rosa AbelDirectorGrant(A)8K—$0
Jun 21, 2021Duncan Gregory ScottCHIEF EXECUTIVE OFFICER, DirectorGrant(A)60K—$0
Jun 21, 2021Grosswald RalphVICE PRESIDENT OF OPERATIONSGrant(A)30K—$0
Jun 21, 2021Walsh AngelaSVP OF FINANCEGrant(A)30K—$0
Apr 6, 2021Duncan Gregory ScottChief Executive Officer, DirectorBuy(P)382$6.36$2K
Apr 5, 2021Duncan Gregory ScottChief Executive Officer, DirectorBuy(P)16K$6.17$97K
Jan 29, 2021Pridgen WilliamDirectorBuy(P)4K$7.47$26K
Jan 28, 2021Walsh AngelaVP of FinanceBuy(P)1K$7.30$7K
Jan 28, 2021Keefer David RDirectorOption exercise(M)2K$7.80$12K
Jan 28, 2021Keefer David RDirectorOption exercise(M)2K—$0
Jan 28, 2021Pridgen WilliamDirectorOption exercise(M)801$7.80$6K
Jan 28, 2021Pridgen WilliamDirectorOption exercise(M)801—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Virios Therapeutics, Inc., SEC CIK 0001818844. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under VIRI and shows every filing by that issuer (also filed as DWTX).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for VIRI